Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina

Francesco Pisani, Cinzia Costa, Daniela Caccamo, Emanuela Mazzon, Gaetano Gorgone, Giancarla Oteri, Paolo Calabresi, Riccardo Ientile

Research output: Contribution to journalArticlepeer-review


The possible neuroprotective effects of two GABAergic drugs, tiagabine (TGB) and vigabatrin (VGB), against N-methyl-d-aspartate (NMDA)-induced excitotoxicity have been investigated in the isolated chick embryo retina model. Retina segments were incubated either with NMDA alone (100 μM) or with NMDA and TGB or VGB (10-1,000 μM, added 5 min before NMDA). Retina damage was assessed after 24 h by measuring lactate dehydrogenase (LDH) activity present in the medium and by histological analysis. Both drugs reduced LDH release in a dose-dependent manner with comparable mean maximal values of 56.6-63.7% achieved at concentration of 1 mM. Histological analysis of retina slices was in line with the biochemical assays and showed partial preservation of drug exposed retina structure with reduced edema especially in the inner plexiform layer. The present data provide pharmacological evidence that both TGB and VGB reduce the severity of NMDA-induced excitotoxic damage. Although an increase in GABAergic transmission might play a role, this in itself is insufficient to explain the neuroprotective effect of the two drugs and the exact mechanism remains to be elucidated.

Original languageEnglish
Pages (from-to)511-515
Number of pages5
JournalExperimental Brain Research
Issue number4
Publication statusPublished - Jun 2006


  • Excitotoxic damage
  • Tiagabine
  • Vigabatrin

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina'. Together they form a unique fingerprint.

Cite this